Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lan Thi Hanh Phi | - |
dc.contributor.author | Sari, Ita Novita | - |
dc.contributor.author | Yang, Ying-Gui | - |
dc.contributor.author | Lee, Sang-Hyun | - |
dc.contributor.author | Jun, Nayoung | - |
dc.contributor.author | Kim, Kwang Seock | - |
dc.contributor.author | Lee, Yun Kyung | - |
dc.contributor.author | Kwon, Hyog Young | - |
dc.date.accessioned | 2021-08-11T13:44:08Z | - |
dc.date.available | 2021-08-11T13:44:08Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1687-966X | - |
dc.identifier.issn | 1687-9678 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6889 | - |
dc.description.abstract | Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to self-renew themselves and differentiate into heterogeneous lineages of cancer cells. Thus, it is important to understand the characteristics and mechanisms by which CSCs display resistance to therapeutic agents. In this review, we highlight the key features and mechanisms that regulate CSC function in drug resistance as well as recent breakthroughs of therapeutic approaches for targeting CSCs. This promises new insights of CSCs in drug resistance and provides better therapeutic rationales to accompany novel anticancer therapeutics. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Hindawi Publishing Corporation | - |
dc.title | Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1155/2018/5416923 | - |
dc.identifier.scopusid | 2-s2.0-85045117998 | - |
dc.identifier.wosid | 000427165400001 | - |
dc.identifier.bibliographicCitation | Stem Cells International, v.2018 | - |
dc.citation.title | Stem Cells International | - |
dc.citation.volume | 2018 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.subject.keywordPlus | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject.keywordPlus | TUMOR-INITIATING CELLS | - |
dc.subject.keywordPlus | ACUTE MYELOID-LEUKEMIA | - |
dc.subject.keywordPlus | ALDEHYDE DEHYDROGENASE-ACTIVITY | - |
dc.subject.keywordPlus | HEDGEHOG-SIGNALING PATHWAY | - |
dc.subject.keywordPlus | SELF-RENEWAL | - |
dc.subject.keywordPlus | PROSTATE-CANCER | - |
dc.subject.keywordPlus | ENDOTHELIAL-CELLS | - |
dc.subject.keywordPlus | SIDE POPULATION | - |
dc.subject.keywordPlus | SOLID TUMORS | - |
dc.subject.keywordAuthor | cancer stem cells | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.